Search Results - "Karim, Farheen"

Panobinostat in combination with bortezomib and dexamethasone in multiply relapsed and refractory myeloma; UK routine care cohort by Maouche, Nadjoua, Kishore, Bhuvan, Bhatti, Zara, Basu, Supratik, Karim, Farheen, Sundararaman, Sharadha, Collings, Freya, Tseu, Bing, Leary, Heather, Ryman, Noel, Reddy, Udaya, Vallance, Grant D, Kothari, Jaimal, Ramasamy, Karthik

“…The combination of panobinostat, bortezomib and dexamethasone (PanBorDex) is available as a treatment option for relapsed refractory multiple myeloma (RRMM)…”
Get full text

Reporting transfusion-related acute lung injury cases by Karim, Farheen, Mansoori, Huma, Rashid, Anila, Moiz, Bushra

“…Background: Transfusion-related acute lung injury (TRALI) is a rare but potentially fatal complication of blood product transfusion. It is felt worldwide that…”
Get full text

Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study by Djebbari, Faouzi, Rampotas, Alexandros, Vallance, Grant, Panitsas, Fotios, Basker, Nanda, Sangha, Gina, Salhan, Beena, Karim, Farheen, Firas, Al-Kaisi, Gudger, Amy, Ngu, Loretta, Poynton, Matt, Lam, Ho Pui Jeff, Morgan, Lowri, Yang, Laura, Young, Jennifer, Walker, Mairi, Tsagkaraki, Ismini, Anderson, Laura, Chauhan, Saleena Rani, Maddams, Rebecca, Soutar, Richard, Triantafillou, Margarita, Prideaux, Steve, Obeidalla, Abubaker, Eyre, Toby A., Bygrave, Ceri, Basu, Supratik, Ramasamy, Karthik

“…There are no real-world data describing infection morbidity in relapsed/refractory myeloma (RRMM) patients treated with anti-CD38 isatuximab in combination…”
Get full text

Performance evaluation of a coagulation laboratory using Sigma metrics by Shaikh, Muhammad Shariq, Ali, Sidra Asad, Rashid, Anila, Karim, Farheen, Moiz, Bushra

“…Purpose Two-thirds of medical decisions are based on laboratory test results. Therefore, laboratories should practice strict quality control (QC) measures…”
Get full text

Delta beta thalassemia: a rare hemoglobin variant by Mansoori, Huma, Asad, Sidra, Rashid, Anila, Karim, Farheen

“…KCI Citation Count: 0…”
Get full text

A T-cell/histiocyte-rich large B-cell lymphoma involving only the bone marrow by Shafiq, Maria, Karim, Farheen

“…KCI Citation Count: 0…”
Get full text

Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK‐Wide Real‐World Dataset by Djebbari, Faouzi, Rampotas, Alexandros, Vallance, Grant, Panitsas, Fotios, Basker, Nanda, Sangha, Gina, Salhan, Beena, Karim, Farheen, Al‐Kaisi, Firas, Gudger, Amy, Ngu, Loretta, Poynton, Matt, Lam, Ho Pui Jeff, Morgan, Lowri, Yang, Laura, Young, Jennifer, Walker, Mairi, Tsagkaraki, Ismini, Anderson, Laura, Chauhan, Saleena Rani, Maddams, Rebecca, Soutar, Richard, Triantafillou, Margarita, Prideaux, Steve, Obeidalla, Abubaker, Bygrave, Ceri, Basu, Supratik, Ramasamy, Karthik

“…Real‐world data on the efficacy and tolerability of isatuximab with pomalidomide and dexamethasone (IsaPomDex) in relapsed/refractory myeloma patients have not…”
Get full text

Acquired haemoglobin F (HbF) in HbA1c analysis predating a diagnosis of myelodysplastic syndrome by Lorde, Nathan, Karim, Farheen, Gama, Rousseau, Kalaria, Tejas

Get more information

Thrombocytopenia and Its Outcome in a Cohort of 350 Pregnant Women in a Tertiary Care Setting by Karim, Farheen, Moiz, Bushra

Get full text

Transfusion transmitted dengue: one donor infects two patients by Karim, Farheen, Nasir, Nadia, Moiz, Bushra

“…Abstract Dengue virus can be transmitted via blood transfusion. We report an interesting case where two surgical patients developed possible transfusion…”
Get full text

Red cell antigen loss in a patient with chronic myeloid leukemia: A case of ABO discrepancy by Shafiq, Maria, Karim, Farheen

“…Abstract Change in ABO antigen expression on the surface of neoplastic cells have been seen for a variety of tumor types. This phenomenon has been linked with…”
Get full text

Eliminating wrong blood transfusions - recent advances by Karim, Farheen, Adil, Salman Naseem

Get full text

Risk of maternal alloimmunization in Southern Pakistan – A study in a cohort of 1000 pregnant women by Karim, Farheen, Moiz, Bushra, Kamran, Nausheen

“…Abstract Background Haemolytic disease of the fetus and the newborn [HDFN] is caused by incompatibility of maternal and fetal erythrocytes. Red blood cell…”
Get full text

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real‐world multicentre UK retrospective analysis by McMillan, Annabel, Basu, Supratik, Karunanithi, Kamaraj, Parkins, Elizabeth, Lau, Edward Yan Ming, Cook, Gordon, Parrish, Christopher, Al‐Kaisi, Firas, Pratt, Guy, Shafeek, Salim, Jenkins, Stephen, Memon, Danish, Bygrave, Ceri, Papanikolaou, Xenofon, Maisel, Tara, Hassan, Sandra, Moosai, Shivir, Chander, Gurvin, Rakesh, Pallav, Kishore, Bhuvan, Karim, Farheen, Talbot, Georgina, Wandroo, Farooq, Yong, Kwee, Popat, Rakesh

“…Summary Daratumumab, bortezomib and dexamethasone (DVd) is approved for patients with relapsed multiple myeloma following the CASTOR phase 3 clinical trial…”
Get full text

Documentation errors in transfusion chain: Challenges and interventions by Moiz, Bushra, Siddiqui, Arsalan Kabir, Sana, Nazish, Sadiq, Muhammed Wahhaab, Karim, Farheen, Ali, Natasha

“…There are several steps in transfusion chain where accurate documentation is critical. This study was conducted to evaluate the frequency of documentation…”
Get full text

Isatuximab with Pomalidomide and Dexamethasone Provides Comparable Efficacy Outcomes in Frail Routine Care Myeloma Patients in a UK-Wide Cohort by Rampotas, Alexandros, Rampotas, Alexandros, Vallance, Grant, Panitsas, Fotios, Basker, Nanda, Sangha, Gina, Salhan, Beena, Karim, Farheen, Al-Kaisi, Firas, Gudger, Amy, Ngu, Loretta, Poynton, Matt, Lam, Ho Pui Jeff, Morgan, Lowri, Yang, Laura, Young, Jennifer, Walker, Mairi, Tsagkaraki, Ismini, Anderson, Laura, Chauhan, Saleena Rani, Maddams, Rebecca, Soutar, Richard, Triantafillou, Margarita, Prideaux, Steve, Obeidalla, Abubaker, Bygrave, Ceri, Basu, Supratik, Ramasamy, Karthik

Get full text

SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study by Shields, Adrian M, Venkatachalam, Srinivasan, Shafeek, Salim, Paneesha, Shankara, Ford, Mark, Sheeran, Tom, Kelly, Melanie, Qureshi, Iman, Salhan, Beena, Karim, Farheen, De Silva, Neelakshi, Stones, Jacqueline, Lee, Sophie, Khawaja, Jahanzeb, Kaudlay, Praveen Kumar, Whitmill, Richard, Kakepoto, Ghulam Nabi, Parry, Helen M, Moss, Paul, Faustini, Sian E, Richter, Alex G, Drayson, Mark T, Basu, Supratik

“…B-cell-depleting agents are among the most commonly used drugs to treat haemato-oncological and autoimmune diseases. They rapidly induce a state of peripheral…”
Get full text

Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings by Rashid, Anila, Moiz, Bushra, Karim, Farheen, Shaikh, Muhammad Shariq, Mansoori, Huma, Raheem, Ahmed

“…Background: The International Society of Thrombosis & Hemostasis (ISTH) bleeding assessment tool (ISTH-BAT) is used to record bleeding symptoms in patients…”
Get full text

Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients by Djebbari, Faouzi, Rampotas, Alexandros, Vallance, Grant, Panitsas, Fotios, Basker, Nanda, Sangha, Gina, Salhan, Beena, Karim, Farheen, Al‐Kaisi, Firas, Gudger, Amy, Ngu, Loretta, Poynton, Matt, Lam, Ho Pui Jeff, Morgan, Lowri, Yang, Laura, Young, Jennifer, Walker, Mairi, Tsagkaraki, Ismini, Anderson, Laura, Chauhan, Saleena Rani, Maddams, Rebecca, Soutar, Richard, Triantafillou, Margarita, Prideaux, Steve, Obeidalla, Abubaker, Eyre, Toby A., Bygrave, Ceri, Kothari, Jaimal, Basu, Supratik, Ramasamy, Karthik

Get full text

Daratumumab, Bortezomib and Dexamethasone (DVd) at First Relapse for Patients with Relapsed/ Refractory Multiple Myeloma (RRMM): A UK Myeloma Research Alliance (UK-MRA) Real-World Multicentre Analysis by McMillan, Annabel, Basu, Supratik, Karunanithi, Kamaraj, Parkins, Elizabeth A., Yan Ming Lau, Edward, Cook, Gordon, Parrish, Christopher, Al-Kaisi, Firas, Pratt, Guy, Shafeek, Salim, Jenkins, Stephen William Hart, Moosai, Shivir, Memon, Danish, Bygrave, Ceri A, Papanikolaou, Xenofon, Maisel, Tara, Hassan, Sandra, Chander, Gurvin, Kishore, Bhuvan, Karim, Farheen, Talbot, Georgina, Wandroo, Farooq A, Bolarinwa, Dunsi, Yong, Kwee, Popat, Rakesh

“…Introduction: Daratumumab in combination with bortezomib and dexamethasone (DVd) demonstrated a superior overall response rates (ORR) and progression free…”
Get full text